| Financial Year |
March 31 2023 |
| Monetary Funds |
504,020,722.04 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
178,282,121.42 |
| Accounts Receivable |
1,287,964,178.18 |
| Advances to Suppliers |
32,704,632.29 |
| Other Receivables |
36,458,971.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
746,709,598.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,506,506.00 |
| Total Current Assets |
3,181,683,974.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
163,962,169.42 |
| Investment Properties |
5,211,362.89 |
| Fixed Assetes |
750,684,007.59 |
| Under-construction Projects |
462,793,032.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
210,531,145.26 |
| R&D expenses |
-- |
| Goodwill |
615,062,026.77 |
| Long-Term Deferred and Prepaid Expenses |
8,997,357.58 |
| Deferred Income Tax Assets |
37,236,275.29 |
| Other Non-Current Assets |
22,546,422.97 |
| Sub-Total of Non-Current Assets |
2,409,144,954.05 |
| Total Assets |
5,590,828,928.96 |
| Short-Term Loans |
692,415,694.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
258,345,269.31 |
| Accounts Payable |
504,131,449.73 |
| Accounts Received In Advance |
253,210.16 |
| Employee Compensation Payable |
34,476,178.53 |
| Taxes Payable |
22,029,220.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,942,668.72 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
270,665,479.02 |
| Other Current Liabilities |
4,884,902.87 |
| Sub-Total of Current Liabilities |
1,869,727,700.71 |
| Long-term Loans |
406,058,823.33 |
| Bonds Payable |
81,086,060.00 |
| Long-Term Accounts Payable |
59,741,008.06 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,769,450.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
566,172,697.56 |
| Total Liabilities |
2,435,900,398.27 |
| Paid-In Capital(Or Share Stock) |
305,402,973.00 |
| Capital Surplus |
1,941,073,527.65 |
| Surplus Reserve |
85,783,989.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
684,535,710.71 |
| Minority Stockholder's Interest |
133,127,575.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,021,800,955.58 |
| Owner's Equity（Stockholder's Equity） |
3,154,928,530.69 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,590,828,928.96 |
